Coherus Biosciences | CHRS - 自己資本および準備金





自己資本および準備金 変化する 日付
AbbVie USD -4.58B 1.35B 2026-09
Acadia Pharmaceuticals USD 1.39B 80.88M 2026-09
Akebia Therapeutics USD 20.37M 4.65M 2026-09
ALKERMES USD 1.86B 56.17M 2026-09
Alnylam Pharmaceuticals USD 3.6B 2.25B 2026-09
Amarin USD 444.41M 796K 2026-09
Amgen USD 14.35B 2.66B 2026-09
Baxter International USD 6.5B 296M 2026-09
Biogen USD 19.04B 194.3M 2026-09
BioMarin Pharmaceutical USD 6.26B 65.66M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Coherus Biosciences USD 60.84M 17.78M 2026-06
Eli Lilly USD 40.27B 6.39B 2026-09
Fujifilm JPY 3.82T 82.7B 2026-09
Gilead Sciences USD 13.04B 1.3B 2026-09
Ironwood Pharmaceuticals USD -97.19M 64.65M 2026-09
Merck USD 44.89B 2.96B 2026-09
Myriad Genetics USD 303.9M 33.5M 2026-06
Pacira USD 712.32M 40.34M 2026-09
Perrigo USD 2.44B 75.4M 2026-09
Pfizer USD 89B 3.81B 2026-09
PTC Therapeutics USD -191.21M 25.85M 2026-09
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Sarepta Therapeutics USD 1.53B 1.06M 2026-09
Teva Pharmaceutical Industries USD 7.98B 226M 2026-09
Vertex Pharmaceuticals USD 20.91B 659.5M 2026-09
Xencor USD 560.43M 57.21M 2026-09
Zoetis USD 3.3B 155M 2026-09